SEC Tracker
Get the app

Maxcyte MXCT

Maxcyte: Enters material agreement, Reports results, Unregistered share sale

Maxcyte (MXCT) filed an 8-K with the SEC on Nov 10, 2026, 8:21 am ET. Source: the filing on SEC EDGAR.

Item 1.01 Enters material agreement, Item 2.02 Reports results, Item 3.02 Unregistered share sale

Form
8-K
Filed
Importance
Major
  1. $105M cash and $20M deferred payments
  2. 20,639,733 shares of common stock
  3. Closing expected before end of 2026

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Maxcyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.